Boston Scientific (NYSE:BSX) last posted its quarterly earnings results on Thursday, October 26th. Following the completion of the transaction, the executive vice president now owns 164,681 shares of the company's stock, valued at approximately $4,647,297.82. The institutional investor held 390,000 shares of the medical and dental instruments company at the end of 2017Q3, valued at $11.38B, down from 420,546 at the end of the previous reported quarter. Adage Capital Partners Gp Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $35.66 billion market cap company. Active Investors often maintain a close study on trading capacity of BSX stock. About 24.99M shares traded or 186.51% up from the average.
Since August 1, 2017, it had 0 buys, and 11 selling transactions for $14.78 million activity. PRIMECAP MANAGEMENT CO/CA/ also announced decreased position in Boston Scientific Corporation (BSX) during the quarter. Acrospire Investment Management LLC grew its position in Boston Scientific by 157.3% during the 2nd quarter.
Among 17 analysts covering Brunswick (NYSE:BC), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 52% are positive. Along with these its last twelve month performance is stands at 5.25% while moved 2.31% for the past six months according to Finviz reported data. The firm has "Buy" rating by BTIG Research given on Sunday, September 6. The company have shares float of 3.57 billion. The company was maintained on Wednesday, November 29 by Canaccord Genuity. Jefferies has "Hold" rating and $2800 target. Piper Jaffray maintained The Cooper Companies, Inc. They now have a $32.00 price objective on the medical equipment provider's stock. However, their relatively high multiples do not necessarily mean their stocks are overpriced and not good buys for the long term. The stock has "Buy" rating by Stifel Nicolaus on Thursday, April 28. Jefferies maintained the shares of BSX in report on Friday, July 28 with "Hold" rating. The firm attains analyst recommendation of 1.70 out of 1-5 scale with week's performance of 0.48%. 15,500 shares were sold by Phalen Michael P., worth $416,559 on Tuesday, August 29. 65 funds opened positions while 204 raised stakes. Canada Pension Plan Invest Board holds 0.05% or 903,489 shares in its portfolio. Daruma Capital Management Llc owns 1.12 million shares or 3.37% of their U.S. portfolio.
Analysts await Genesco Inc. The stock has "Hold" rating by Oppenheimer on Monday, May 1. Third Avenue Mngmt Limited Liability holds 0.72% in KeyCorp (NYSE:KEY) or 851,818 shares. The company has a quick ratio of 0.50, a current ratio of 0.72 and a debt-to-equity ratio of 0.58. Portolan Capital Management Llc, a Massachusetts-based fund reported 98,717 shares. Its up 0.01, from 1.03 in 2017Q2. It increased, as 33 investors sold BSX shares while 166 reduced holdings. (NYSE:ITW) shares. $7.62 million worth of Illinois Tool Works Inc. Goelzer Mngmt reported 0.26% stake. State Treasurer State Of Michigan has invested 0.1% in Boston Scientific Corporation (NYSE:BSX). Prelude Capital Mgmt Ltd reported 46,540 shares or 0.12% of all its holdings. (NYSE:COO). Quantitative Investment Limited Liability invested in 0.08% or 30,600 shares. Nomura Asset accumulated 0.09% or 233,651 shares. Hanseatic Management Services Inc.'s holdings in Boston Scientific Corporation were worth $3,648,000 as of its most recent SEC filing. Acadian Asset Mgmt Ltd Liability has invested 0.06% of its portfolio in The Cooper Companies, Inc. Walleye Trading Ltd Company stated it has 22,865 shares or 0% of all its holdings.
Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. 443,000 are owned by Gabelli Funds Limited Liability Co. Amer Century Cos Incorporated holds 34,480 shares or 0% of its portfolio.
Boston Scientific Corporation (NYSE:BSX) also in plain sight to attract passive investors, shares in most recent trading session ascend 8.33% after traded at $27.96. Therefore 40% are positive. Evercore ISI assumed coverage on shares of Boston Scientific in a report on Wednesday, January 3rd. Needham has "Buy" rating and $21 target. Needham maintained it with "Buy" rating and $32 target in Thursday, June 22 report. Piper Jaffray maintained the shares of ABMD in report on Wednesday, August 5 with "Hold" rating. The "percentage off the 52-week high or low" refers to when a stock current price is relative to where it has traded over the last 52 weeks. The firm earned "Buy" rating on Sunday, November 5 by RBC Capital Markets. UBS has "Neutral" rating and $25 target. The company was reinitiated on Monday, August 10 by Credit Suisse. They set a "buy" rating and a $36.00 price objective for the company. The stock of Boston Scientific Corporation (NYSE:BSX) has "Buy" rating given on Monday, October 2 by RBC Capital Markets.
Greenwood Capital Associates Llc, which manages about $970.61 million and $402.23 million US Long portfolio, decreased its stake in Vanguard Intl Eq Ind (VPL) by 76,025 shares to 13,161 shares, valued at $898,000 in 2017Q3, according to the filing.